Filing Details
- Accession Number:
- 0001078782-21-000463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 11:40:19
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 11:40:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
93314 | Volitionrx Ltd | VNRX | In Vitro & In Vivo Diagnostic Substances (2835) | 911949078 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1852492 | Kim Nguyen | 13215 Bee Cave Parkway Suite 125, Galleria Oaks B Austin TX 78738 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-14 | 2,000 | $3.20 | 2,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,000 | Direct | |
Common Stock | 30,556 | Indirect | By Spouse |
Footnotes
- These restricted stock units are subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 03/25/22 and 03/25/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.